SCHEMBL18310249

SCHEMBL18310249

c1ccc(-c2cccc(-c3ccc(-n4c5ccccc5c5ccc(-c6cccc(N(c7ccc8ccccc8c7)c7cccc8ccccc78)c6)cc54)cc3)c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 1/20 0.36
▸ F10 P00742 1/20 0.36
▸ PRSS1 P07477 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ HDAC4 P56524 1/20 0.32
▸ RXRA P19793 1/20 0.31
▸ RXRB P28702 1/20 0.31
▸ PER2 O15055 1/20 0.30
▸ CRY1 Q16526 1/20 0.30
▸ CRY2 Q49AN0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16947074 1.00 F2 (0.36) F2F10PRSS1KDM4EATM
SCHEMBL16947137 0.97 KDM4E (0.38) F2F10PRSS1KDM4EATM
SCHEMBL17041062 0.96 F2 (0.34) F2F10PRSS1KDM4EATM
SCHEMBL17056415 0.96 L3MBTL1 (0.39) F2F10PRSS1KDM4EATM
SCHEMBL18310205 0.94 KDM4E (0.38) F2F10PRSS1KDM4EATM
SCHEMBL16947133 0.94 KDM4E (0.38) F2F10PRSS1KDM4EATM
SCHEMBL19238742 0.93 KDM4E (0.40) F2F10PRSS1KDM4EATM
SCHEMBL11922060 0.92 KDM4E (0.39) F2F10PRSS1KDM4EATM
SCHEMBL18561231 0.92 F2 (0.34) F2F10PRSS1KDM4EATM
SCHEMBL19738439 0.92 KDM4E (0.38) F2F10PRSS1KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200243771-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2020-07-30 — — US disclosed
US-10396291-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2019-08-27 — — US disclosed
US-20190051836-A2 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-02-14 — — US disclosed
US-20160365517-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2016-12-15 — — US disclosed
US-20160365517-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2016-12-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10396291-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof GPX1, NFE2L2, LEF1 F2 1198/4885F10 1511/4885PRSS1 3798/4885
US-20200243771-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF GPX1, LEF1, NFE2L2 F2 1059/4885F10 1269/4885PRSS1 3794/4885
US-20160365517-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF GPX1, NFE2L2, LEF1 F2 1198/4885F10 1511/4885PRSS1 3798/4885
US-20190051836-A2 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF GPX1, NFE2L2, LEF1 F2 1198/4885F10 1511/4885PRSS1 3798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback